|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
5.43/-1.14
|
企业价值
9.20B
|
资产负债 |
每股账面净值
7.56
|
现金流量 |
现金流量率
--
|
损益表 |
收益
61.28M
|
每股收益
0.10
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/28 05:58 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients. |